Systemic Opioids for Dyspnea in Cancer Patients: A Real-world Observational Study

Parshall, 2012, An Official American Thoracic Society Statement: update on the mechanisms, assessment, and management of Dyspnea, American Respiratory Critical Care Medicine, 185, 435, 10.1164/rccm.201111-2042ST Bruera, 2000, The frequency and correlates of Dyspnea in patients with advanced cancer, J Pain Symptom Manage, 19, 357, 10.1016/S0885-3924(00)00126-3 Chiu, 2004, Dyspnea and its correlates in taiwanese patients with terminal cancer, J Pain Symptom Manage, 28, 123, 10.1016/j.jpainsymman.2003.11.009 Reuben, 1986, Dyspnea in terminally ill cancer patients, Chest, 89, 234, 10.1378/chest.89.2.234 Skaug, 2007, Prevalence and predictors of symptoms in the terminal stage of lung cancer: a community study, Chest, 131, 389, 10.1378/chest.06-1233 Allard, 1999, How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial, J Pain Symptom Manage, 17, 256, 10.1016/S0885-3924(98)00157-2 Bruera, 1993, Subcutaneous morphine for dyspnea in cancer patients, Ann Intern Med, 119, 906, 10.7326/0003-4819-119-9-199311010-00007 Bruera, 1990, Effects of morphine on the dyspnea of terminal cancer patients, J Pain Symptom Manage, 5, 341, 10.1016/0885-3924(90)90027-H Mazzocato, 1999, The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial, Ann Oncol, 10, 1511, 10.1023/A:1008337624200 Hui, 2021, Management of Dyspnea in Advanced Cancer: ASCO guideline, J clinical oncol, 39, 1389, 10.1200/JCO.20.03465 Hui, 2020, Management of breathlessness in patients with cancer: ESMO Clinical Practice Guidelines(†), ESMO open, 5, 10.1136/esmoopen-2020-001038 Yamaguchi, 2016, Treatment Recommendations for Respiratory Symptoms in Cancer Patients: clinical Guidelines from the Japanese Society for Palliative Medicine, J Palliat Med, 19, 925, 10.1089/jpm.2016.0145 Yamaguchi, 2018, Efficacy of immediate-release oxycodone for dyspnoea in cancer patient: cancer dyspnoea relief (CDR) trial, Japanese J Clin Oncol, 48, 1070, 10.1093/jjco/hyy139 Charles, 2008, Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline, J Pain Symptom Manage, 36, 29, 10.1016/j.jpainsymman.2007.08.016 Hui, 2014, Effects of prophylactic subcutaneous fentanyl on exercise-induced breakthrough dyspnea in cancer patients: a preliminary double-blind, randomized, controlled trial, J Pain Symptom Manage, 47, 209, 10.1016/j.jpainsymman.2013.03.017 Pinna, 2015, A randomized crossover clinical trial to evaluate the efficacy of oral transmucosal fentanyl citrate in the treatment of dyspnea on exertion in patients with advanced cancer, American J Hospice Palliative Care, 32, 298, 10.1177/1049909113513063 Hui, 2016, Impact of Prophylactic Fentanyl Pectin Nasal Spray on Exercise-Induced Episodic Dyspnea in Cancer Patients: A Double-Blind, Randomized Controlled Trial, J Pain Symptom Manage, 52 Simon, 2016, EffenDys-Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Patients With Advanced Cancer: a multicenter, open-label, randomized, Morphine-Controlled, Crossover, Phase II Trial, J Pain Symptom Manage, 52, 617, 10.1016/j.jpainsymman.2016.05.023 Hui, 2017, Effect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: a pilot double-blind randomized controlled trial, J Pain Symptom Manage, 54, 798, 10.1016/j.jpainsymman.2017.08.001 Hui, 2019, Prophylactic Fentanyl Sublingual Spray for Episodic Exertional Dyspnea in Cancer Patients: a pilot double-blind randomized controlled trial, J Pain Symptom Manage, 58, 605, 10.1016/j.jpainsymman.2019.06.024 Kloke, 2015, Treatment of dyspnoea in advanced cancer patients: ESMO Clinical Practice Guidelines, Ann Oncol, 26, v169, 10.1093/annonc/mdv306 Dean, 2004, Opioids in renal failure and dialysis patients, J Pain Symptom Manage, 28, 497, 10.1016/j.jpainsymman.2004.02.021 King, 2011, A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project, Palliat Med, 25, 525, 10.1177/0269216311406313 Yamaguchi, 2019, The Current Practice of Opioid for Cancer Dyspnea: The Result From the Nationwide Survey of Japanese Palliative Care Physicians, J Pain Symptom Manage, 58, 10.1016/j.jpainsymman.2019.06.006 Mori, 2021, How successful is parenteral oxycodone for relieving terminal Cancer Dyspnea compared with Morphine? a multicenter prospective observational study, J Pain Symptom Manage, 62, 336, 10.1016/j.jpainsymman.2020.11.037 Matsuda, 2022, Research policy in supportive care and palliative care for cancer dyspnea, Jpn J Clin Oncol, 52, 260, 10.1093/jjco/hyab193 Collins, 2015, A Systematic Review of the Use of the Palliative Care Outcome Scale and the Support Team Assessment Schedule in Palliative Care, J Pain Symptom Manage, 50, 10.1016/j.jpainsymman.2015.07.015 Sakurai, 2019, Validation of the Integrated Palliative care Outcome Scale (IPOS) - Japanese Version, Jpn J Clin Oncol, 49, 257, 10.1093/jjco/hyy203 Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. Available at:https://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_5x7.pdf. Accessed September 16, 2019. Takahashi, 2019, Effects of Oral Morphine on Dyspnea in Patients with Cancer: response rate, predictive factors, and clinically meaningful change (CJLSG1101), Oncologist, 24, e583, 10.1634/theoncologist.2018-0468 Matsuda, 2020, Physician-perceived predictive factors for the effectiveness of drugs for treating Cancer Dyspnea: results of a nationwide survey of Japanese Palliative Care Physicians, Palliat Med Rep, 1, 97, 10.1089/pmr.2020.0050 Hui, 2015, Minimal clinically important differences in the Edmonton symptom assessment scale in Cancer patients: a prospective, multicenter study, Cancer, 121, 3027, 10.1002/cncr.29437 Norman, 2003, Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation, Med Care, 41, 582, 10.1097/01.MLR.0000062554.74615.4C Chen, 2022, Real-world opioid prescription to patients with serious, non-malignant, respiratory illnesses and chronic breathlessness, Intern Med J, 52, 1925, 10.1111/imj.15770 Maltoni, 2005, Prognostic factors in advanced Cancer patients: evidence-based clinical recommendations–a study by the steering committee of the European Association for Palliative Care, J Clin Oncol, 23, 6240, 10.1200/JCO.2005.06.866 Stone, 2007, Predicting prognosis in patients with advanced cancer, Ann Oncol, 18, 971, 10.1093/annonc/mdl343 Mori, 2020, How successful are we in relieving terminal dyspnea in cancer patients? A real-world multicenter prospective observational study, Support Care Cancer, 28, 3051, 10.1007/s00520-019-05081-9